Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus—The case of Belgium
- 1 July 1993
- journal article
- Published by Elsevier in Social Science & Medicine
- Vol. 37 (2) , 173-181
- https://doi.org/10.1016/0277-9536(93)90453-b
Abstract
No abstract availableKeywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Chronicity rate of hepatitis B virus infection in the families of 60 hepatitis B surface antigen positive chronic carrier children: Role of horizontal transmissionEuropean Journal of Pediatrics, 1992
- Cost Effectiveness of Antenatal Hepatitis B Screening and Vaccination of InfantsAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1990
- Hepatitis B: the diseaseVaccine, 1990
- Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothersJAMA, 1989
- Hepatitis B: prevention in primary care.BMJ, 1989
- Routine prenatal screening for hepatitis B surface antigenPublished by American Medical Association (AMA) ,1988
- Cost-effectiveness of prenatal screening and immunization for hepatitis B virusJAMA, 1988
- Liver cirrhosis associated with chronic hepatitis B virus infection in childhoodThe Journal of Pediatrics, 1986
- PREVENTION OF CHRONIC HBsAG CARRIER STATE IN INFANTS OF HBsAG-POSITIVE MOTHERS BY HEPATITIS B IMMUNOGLOBULINThe Lancet, 1979
- Mechanisms of Maternal-Fetal Transmission of Hepatitis B VirusThe Journal of Infectious Diseases, 1978